| Literature DB >> 32274094 |
Rui Zhao1, Jiawei Qiu1, Jinlin Wu1, Wenxiang Jiang1, Enzehua Xie1, Wei Gao1, Cuntao Yu1, Juntao Qiu1.
Abstract
BACKGROUND: To evaluate whether the heated humidified ventilation can effectively maintain core temperature and improve prognosis in normothermic thoraco-abdominal aortic aneurysm repair surgery.Entities:
Keywords: Aortic dissection; aortic aneurysm; humidity; hypothermia
Year: 2020 PMID: 32274094 PMCID: PMC7139055 DOI: 10.21037/jtd.2020.01.61
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Patient preoperative information
| Variable | Heated Humidifiers & Water Blanket, n=15 | Water Blanket, n=15 | P value |
|---|---|---|---|
| Age (years) | 47.07±14.02 | 40.73±13.98 | 0.223 |
| Male | 1 (6.67) | 4 (26.67) | 0.33 |
| Height (cm) | 176.93±8.84 | 176.33±11.69 | 0.875 |
| Weight (kg) | 79.07±13.39 | 75.27±13.15 | 0.439 |
| BMI (kg/m2) | 25.34±4.26 | 24.33±4.51 | 0.535 |
| Hypertension | 8 (53.33) | 9 (60.0) | 1 |
| Diabetes mellitus | 1 (6.67) | 1 (6.67) | 1 |
| Chronic renal failure | 0 (0) | 0 (0) | 1 |
| Marfan syndrome | 3 (20.0) | 4 (26.67) | 1 |
| Smoke | 11 (73.33) | 6 (40%) | 0.13 |
| History of cardiac/aortic surgery | 10 (66.67) | 12 (80.0) | 0.68 |
| COPD | 0 (0) | 0 (0) | 1 |
| EF (%) | 61.53±9.44 | 61.99±4.18 | 0.87 |
| WBC (109/L) | 6.88±1.81 | 6.93±2.83 | 0.95 |
| Hb (g/L) | 138.33±22.46 | 129.73±25.43 | 0.34 |
| Platelet (109/L) | 193.46±66.66 | 183±50.33 | 0.63 |
| PT (s) | 14.27±2.51 | 14.51±2.23 | 0.78 |
| INR | 1.12±0.26 | 1.14±0.23 | 0.8 |
| RR (n/minute) | 18.6±2.59 | 18.2±3.71 | 0.73 |
| Preoperative temperature (°C) | 36.43±0.24 | 36.29±0.53 | 0.36 |
BMI, body mass index; COPD, chronic obstructive pulmonary disease; EF, ejection fraction; WBC, white blood cell count; Hb, hemoglobin; PT, prothrombin time; INR, international normalized ratio; RR, respiratory rate.
Figure 1Patient enrolment flow diagram. This illustrates the flow of all the patients screened (including those who were excluded).
Intraoperative temperature
| Operation time | Heated Humidifiers & Water Blanket (°C) | Water Blanket (°C) | P value |
|---|---|---|---|
| 0 h | 36.29±0.59 | 36.36±0.48 | 0.736 |
| 0.5 h | 36.06±0.56 | 36.05±0.53 | 0.947 |
| 1 h | 35.75±0.52 | 35.69±0.61 | 0.773 |
| 1.5 h | 35.55±0.67 | 35.4±0.65 | 0.548 |
| 2 h | 35.45±0.47 | 35.24±0.59 | 0.284 |
| 2.5 h | 35.32±0.45 | 35.29±0.56 | 0.887 |
| 3 h | 35.37±0.46 | 35.41±0.70 | 0.855 |
| 3.5 h | 35.24±0.56 | 35.47±0.82 | 0.385 |
| 4 h | 35.25±0.53 | 35.48±0.78 | 0.360 |
| 4.5 h | 35.33±0.58 | 35.49±0.85 | 0.569 |
| 5 h | 35.38±0.70 | 35.51±0.88 | 0.664 |
| 5.5 h | 35.54±0.69 | 35.48±0.78 | 0.826 |
| 6 h | 35.56±0.77 | 35.5±0.78 | 0.833 |
| End | 35.84±0.89 | 35.79±0.7 | 0.856 |
| Tr | 1.63±0.65 | 1.67±0.45 | 0.821 |
| T, rm | 36.6±0.92 | 36.41±1.16 | 0.617 |
Tr, temperature range; T, rm, temperature in recovery room.
Figure 2Intraoperative temperature curve, measured every half hour (°C).
Intraoperative coagulation
| Variable | Heated Humidifiers & Water Blanket | Water Blanket | P value |
|---|---|---|---|
| Duration of the procedure (h) | 10.19±2.71 | 9.89±3.26 | 0.788 |
| ACT (s) | 522.27±175.17 | 675.79±197.93 | 0.035 |
| Prothrombin complex (μ) | 1,080±758.95 | 1,221.43±819.17 | 0.63 |
| Tranexamic acid, TXA (g) | 4.51±1.71 | 6.43±4.94 | 0.167 |
| Coagulation factor VIIa (mg) | 1.33±1.45 | 1.5±1.95 | 0.795 |
| Human fibrinogen (g) | 2.77±1.21 | 2.75±0.8 | 0.966 |
| Hb, min (g/L) | 81.73±20.38 | 70.45±28.2 | 0.25 |
| RBC input (μ) | 5.87±9.61 | 4.89±6.13 | 0.75 |
| Platelet input (μ) | 1.93±0.88 | 2.43±0.65 | 0.098 |
| Plasma input (mL)* | 400 [0–800] | 500 [0–900] | 0.53 |
*, data were presented by IQR. ACT, activated clotting time; Hb, min: the minimum hemoglobin; RBC, red blood cell.
Postoperative outcomes
| Variable | Heated Humidifiers & Water Blanket, n=15 | Water Blanket, n=15 | P value |
|---|---|---|---|
| In-hospital mortality, n (%) | 2 (13.33) | 3 (20.00) | 1 |
| Pneumonia, n (%) | 4 (26.67) | 8 (53.33) | 0.264 |
| Respiratory failure, n (%) | 1 (6.67) | 3 (20.00) | 0.598 |
| Reintubation, n (%) | 0 (0.00) | 0 (0.00) | 1 |
| Wound infection, n (%) | 1 (6.67) | 3 (20.00) | 0.598 |
| Resternotomy, n (%) | 1 (6.67) | 3 (20.00) | 0.598 |
| CRRT, n (%) | 3 (20.00) | 6 (40.00) | 0.427 |
| Paralysis, n (%) | 2 (13.33) | 1 (6.67) | 1 |
| Respirator time (h)* | 23 [13–67] | 37 [12–85] | 0.77 |
| ICU stay time (h) | 154.03±132.50 | 213.83±291.15 | 0.82 |
| ACT, postoperative (s) | 207.47±67.04 | 237.08±93.81 | 0.3 |
*, data were presented by IQR. CRRT, continuous renal replacement therapy; ICU, intensive care unit; ACT, activated clotting time.